Yerevan < Yokohama < Yokohama

Facettes : AffPays.f

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000156 (2020)	Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon]	Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients.
000943 (2019)	Yoshiaki Matsushima [Japon] ; Akinobu Hayashi [Japon] ; Kento Mizutani [Japon] ; Makoto Kondo [Japon] ; Yasuo Nakai [Japon] ; Koji Habe [Japon] ; Yukie Yamaguchi [Japon] ; Yuji Kozuka [Japon] ; Hiroki Wakabayashi [Japon] ; Keiichi Yamanaka [Japon]	Psoriasiform Dermatitis Developing during Treatment of Juvenile Idiopathic Arthritis with Tocilizumab
000C46 (2019)	Naomi Tsuchida [Japon] ; Yohei Kirino [Japon] ; Yutaro Soejima [Japon] ; Masafumi Onodera [Japon] ; Katsuhiro Arai [Japon] ; Eiichiro Tamura [Japon] ; Takashi Ishikawa [Japon] ; Toshinao Kawai [Japon] ; Toru Uchiyama [Japon] ; Shigeru Nomura [Japon] ; Daisuke Kobayashi [Japon] ; Masataka Taguri [Japon] ; Satomi Mitsuhashi [Japon] ; Takeshi Mizuguchi [Japon] ; Atsushi Takata [Japon] ; Noriko Miyake [Japon] ; Hideaki Nakajima [Japon] ; Satoko Miyatake [Japon] ; Naomichi Matsumoto [Japon]	Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet’s disease
001861 (2017)	Tomo Nozawa [Japon] ; Tomoyuki Imagawa [Japon] ; Shuichi Ito [Japon]	Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
002614 (2014)	Koji Chiba [Japon] ; Hiroyuki Yoshitsugu [États-Unis] ; Yuto Kyosaka [Japon] ; Satofumi Iida [Japon] ; Koichiro Yoneyama [Japon] ; Takahiko Tanigawa [Allemagne] ; Takashi Fukushima [Japon] ; Masaki Hiraoka [Japon]	A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?
002635 (2014)	Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto	Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan
002638 (2014)	Chie Aoki [Japon] ; Yutaka Inaba [Japon] ; HYONMIN CHOE [Japon] ; Utako Kaneko [Japon] ; Ryoki Hara [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Masaaki Mori [Japon] ; Mari S. Oba [Japon] ; Shumpei Yokota [Japon] ; Tomoyuki Saito [Japon]	Discrepancy Between Clinical and Radiological Responses to Tocilizumab Treatment in Patients with Systemic-onset Juvenile Idiopathic Arthritis
002769 (2013)	Yukinori Okada [États-Unis] ; Di Wu [États-Unis, Australie] ; Gosia Trynka [États-Unis] ; Towfique Raj [États-Unis] ; Chikashi Terao [Japon] ; Katsunori Ikari [Japon] ; Yuta Kochi [Japon] ; Koichiro Ohmura [Japon] ; Akari Suzuki [Japon] ; Shinji Yoshida [Japon] ; Robert R. Graham [États-Unis] ; Arun Manoharan [États-Unis] ; Ward Ortmann [États-Unis] ; Tushar Bhangale [États-Unis] ; Joshua C. Denny [États-Unis] ; Robert J. Carroll [États-Unis] ; Anne E. Eyler [États-Unis] ; Jeffrey D. Greenberg [États-Unis] ; Joel M. Kremer [États-Unis] ; Dimitrios A. Pappas [États-Unis] ; Lei Jiang [République populaire de Chine] ; Jian Yin [République populaire de Chine] ; Lingying Ye [République populaire de Chine] ; Ding-Feng Su [République populaire de Chine] ; Jian Yang [Australie] ; Gang Xie [Canada] ; Ed Keystone [Canada] ; Harm-Jan Westra [Pays-Bas] ; T Nu Esko [Estonie, États-Unis] ; Andres Metspalu [Estonie] ; Xuezhong Zhou [République populaire de Chine] ; Namrata Gupta [États-Unis] ; Daniel Mirel [États-Unis] ; Eli A. Stahl [États-Unis] ; Dorothée Diogo [États-Unis] ; Jing Cui [États-Unis] ; Katherine Liao [États-Unis] ; Michael H. Guo [États-Unis] ; Keiko Myouzen [Japon] ; Takahisa Kawaguchi [Japon] ; Marieke J. H. Coenen [Pays-Bas] ; Piet L. C. M. Van Riel [Pays-Bas] ; Mart A. F. J. Van De Laar [Pays-Bas] ; Henk-Jan Guchelaar [Pays-Bas] ; Tom W. J. Huizinga [Pays-Bas] ; Philippe Dieudé [France] ; Xavier Mariette [France] ; S. Louis Bridges [États-Unis] ; Alexandra Zhernakova [Pays-Bas] ; Rene E. M. Toes [Pays-Bas] ; Paul P. Tak [Pays-Bas, Royaume-Uni] ; Corinne Miceli-Richard [France] ; So-Young Bang [Corée du Sud] ; Hye-Soon Lee [Corée du Sud] ; Javier Martin [Espagne] ; Miguel A. Gonzalez-Gay [Espagne] ; Luis Rodriguez-Rodriguez [Espagne] ; Solbritt Rantap Dahlqvist [Suède] ; Lisbeth Rlestig [Suède] ; Hyon K. Choi [États-Unis] ; Yoichiro Kamatani [France] ; Pilar Galan [France] ; Mark Lathrop [Canada] ; Steve Eyre [Royaume-Uni] ; John Bowes [Royaume-Uni] ; Anne Barton [Royaume-Uni] ; Niek De Vries [Pays-Bas] ; Larry W. Moreland [États-Unis] ; Lindsey A. Criswell [États-Unis] ; Elizabeth W. Karlson [États-Unis] ; Atsuo Taniguchi [Japon] ; Ryo Yamada [Japon] ; Michiaki Kubo [Japon] ; Jun S. Liu [États-Unis] ; Sang-Cheol Bae [Corée du Sud] ; Jane Worthington [Royaume-Uni] ; Leonid Padyukov [Suède] ; Lars Klareskog [Suède] ; Peter K. Gregersen [États-Unis] ; Soumya Raychaudhuri [États-Unis, Royaume-Uni] ; Barbara E. Stranger [États-Unis] ; Philip L. De Jager [États-Unis] ; Lude Franke [Pays-Bas] ; Peter M. Visscher [Australie] ; Matthew A. Brown [Australie] ; Hisashi Yamanaka [Japon] ; Tsuneyo Mimori [Japon] ; Atsushi Takahashi [Japon] ; Huji Xu [République populaire de Chine] ; Timothy W. Behrens [États-Unis] ; Katherine A. Siminovitch [Canada] ; Shigeki Momohara [Japon] ; Fumihiko Matsuda [Japon] ; Kazuhiko Yamamoto [Japon] ; Robert M. Plenge [États-Unis]	Genetics of rheumatoid arthritis contributes to biology and drug discovery
002857 (2013)	Shumpei Yokota [Japon] ; Tomoyuki Imagawa [Japon] ; Masaaki Mori [Japon] ; Takako Miyamae [Japon] ; Syuji Takei [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Takuji Murata [Japon] ; Mari Miyoshi [Japon] ; Minako Tomiita [Japon] ; Norihiro Nishimoto [Japon] ; Tadamitsu Kishimoto [Japon]	Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan
002937 (2013)	A. Ihata [Japon] ; D. Kishimoto [Japon] ; T. Uehara [Japon] ; M. Hama [Japon] ; R. Yoshimi [Japon] ; A. Ueda [Japon] ; M. Takeno [Japon] ; Y. Ishigatsubo [Japon]	THU0448 The Profile of Musculoskeletal Ultrasonography in Patients with Adult Onset Still Disease.
002A51 (2013)	K. Ishii ; Y. Mochida ; K. Harigane ; Y. Yamada ; N. Mitsugi ; T. Saito [Japon]	THU0062 Analysis of perioperative clinical features and complications in patients with rheumatoid arthritis treated with biologic agents
002B38 (2013)	M. Takeno ; H. Ideguchi ; A. Suda ; R. Watanabe ; H. Kikuchi [Japon] ; H. Nagafuchi ; M. Kuwana [Japon] ; K. Saito ; S. Hirohata ; Y. Ishigatsubo [Japon]	SAT0159 Clinical Features of Japanese Patients with Vasculo- BehÇEt’S Disease: A Multicenter Study by BehÇEt’S Disease Research Committee, MHLW
002B39 (2013)	Y. Mochida ; K. Ishii ; K. Harigane ; Y. Yamada ; N. Mitsugi ; T. Saito [Japon]	SAT0156 Histological and immunohistochemical analyses of surgically resected synovial tissues in patients with rheumatoid arthritis treated with/without biological agents
002C95 (2013)	T. Miyamae ; T. Nozawa [Japon] ; M. Kikuchi ; T. Kizawa ; T. Imagawa ; S. Yokota	OP0178 Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
002E91 (2013)	A. Ihata ; H. Hagiyama ; S. Nagaoka ; J. Obata ; K. Miyachi ; H. Yamada ; S. Hirohata ; N. Koido ; M. Yamasaki ; K. Miyagi ; S. Ohno [Japon] ; D. Kishimoto ; K. Takase ; M. Hama ; R. Yoshimi ; A. Ueda ; M. Takeno ; Y. Ishigatsubo	FRI0104 Cohort study of infectious disease risk management in RA patients receiving tocilizumab at 48 weeks (ACT4U-study48)
003572 (2012)	Ryoko Sakai [Japon] ; Michi Tanaka [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Ryuji Koike [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Satoshi Ito [Japon] ; Takayuki Sumida [Japon] ; Atsushi Ihata [Japon] ; Yoshiaki Ishigatsubo [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon] ; Atsuo Nakajima [Japon] ; Naoto Tamura [Japon] ; Takao Fujii [Japon] ; Hiroaki Dobashi [Japon] ; Shigeto Tohma [Japon] ; Takahiko Sugihara [Japon] ; Yukitaka Ueki [Japon] ; Akira Hashiramoto [Japon] ; Atsushi Kawakami [Japon] ; Noboru Hagino [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]	Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules
003678 (2012)	Takahiko Sugihara [Japon] ; Naoko Okiyama [Japon] ; Naoto Watanabe [Japon] ; Nobuyuki Miyasaka [Japon] ; Hitoshi Kohsaka [Japon]	Interleukin‐1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice
003697 (2012)	Tomoyuki Imagawa [Japon] ; Syuji Takei [Japon] ; Hiroaki Umebayashi [Japon] ; Kenichi Yamaguchi [Japon] ; Yasuhiko Itoh [Japon] ; Toshinao Kawai [Japon] ; Naomi Iwata [Japon] ; Takuji Murata [Japon] ; Ikuo Okafuji [Japon] ; Mari Miyoshi [Japon] ; Yasuhiro Onoe [Japon] ; Yoshifumi Kawano [Japon] ; Noriko Kinjo [Japon] ; Masaaki Mori [Japon] ; Neelufar Mozaffarian [États-Unis] ; Hartmut Kupper [Allemagne] ; Sourav Santra [Inde] ; Gina Patel [États-Unis] ; Shinichi Kawai [Japon] ; Shumpei Yokota [Japon]	Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
003993 (2011)	Yutaka Inaba [Japon] ; Remi Ozawa [Japon] ; Tomoyuki Imagawa [Japon] ; Masaaki Mori [Japon] ; Yoshinori Hara [Japon] ; Takako Miyamae [Japon] ; Chie Aoki [Japon] ; Tomoyuki Saito [Japon] ; Shumpei Yokota [Japon]	Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment
003A57 (2011)	Masahiko Suzuki [Japon] ; Keiichiro Nishida [Japon] ; Satoshi Soen [Japon] ; Hiromi Oda [Japon] ; Hiroshi Inoue [Japon] ; Atsushi Kaneko [Japon] ; Kenji Takagishi [Japon] ; Takaaki Tanaka [Japon] ; Tsukasa Matsubara [Japon] ; Naoto Mitsugi [Japon] ; Yuichi Mochida [Japon] ; Shigeki Momohara [Japon] ; Toshihito Mori [Japon] ; Toru Suguro [Japon]	Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association
003A66 (2011)	Maasa Hama [Japon] ; Takeaki Uehara [Japon] ; Kaoru Takase [Japon] ; Atsushi Ihata [Japon] ; Atsuhisa Ueda [Japon] ; Mitsuhiro Takeno [Japon] ; Kazuya Shizukuishi [Japon] ; Ukihide Tateishi [Japon] ; Yoshiaki Ishigatsubo [Japon]	Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i -k "Yokohama" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i  \
                -Sk "Yokohama" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Yokohama
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021